Additionally, IHC analysis of FFPE samples from three patients with untreated SCLC revealed CD94 (an NK marker) positivity in 3,548 (0.36%) out of 973,346 tumor cells, as quantified by Aipathwell software (Supplementary Fig. 4e). This evidence concerns the gene KLRD1 and neoplasm.